Search research articles
Contact Us
Filters
Showing results (41-50 of 51) with videos related to
Page
of 6
Sort By:
Clinical Therapeutics
|
October 10, 2025
Efficacy and Safety of Rosuvastatin/Amlodipine FDC in Patients With Hypertension and Dyslipidemia: A Multicenter, Prospective, Observational Study
Jae Hyoung Park, Kyung Hoon Cho, Seong-Il Woo, et al.
BMJ Open
|
October 14, 2017
Study protocol for a randomised controlled trial: harmonising optimal strategy for treatment of coronary artery stenosis - coronary intervention with next-generation drug-eluting stent platforms and abbreviated dual antiplatelet therapy (HOST-IDEA) trial
Chi-Hoon Kim, Jung-Kyu Han, Han-Mo Yang, et al.
Journal of Korean Medical Science
|
January 23, 2024
Prognostic Implication of Platelet Reactivity According to Left Ventricular Systolic Dysfunction Status in Patients Treated With Drug-Eluting Stent Implantation: Analysis of the PTRG-DES Consortium
Donghoon Han, Sun-Hwa Kim, Dong Geum Shin, et al.
Cardiovascular Therapeutics
|
August 11, 2016
Effect of fixed-dose combinations of ezetimibe plus rosuvastatin in patients with primary hypercholesterolemia: MRS-ROZE (Multicenter Randomized Study of ROsuvastatin and eZEtimibe)
Kyung-Jin Kim, Sang-Hyun Kim, Young Won Yoon, et al.
Clinical Therapeutics
|
November 16, 2019
Ezetimibe and Rosuvastatin Combination Treatment Can Reduce the Dose of Rosuvastatin Without Compromising Its Lipid-lowering Efficacy
Moo-Yong Rhee, Kyung-Jin Kim, Sang-Hyun Kim, et al.
European Heart Journal. Digital Health
|
July 24, 2025
Novel artificial intelligence model using electrocardiogram for detecting acute myocardial infarction needing revascularization
Kyung Hoon Cho, Young Hoon Ji, Sunghoon Joo, et al.
Circulation
|
March 5, 2023
Comparison of 3- to 6-Month Versus 12-Month Dual Antiplatelet Therapy After Coronary Intervention Using the Contemporary Drug-Eluting Stents With Ultrathin Struts: The HOST-IDEA Randomized Clinical Trial
Jung-Kyu Han, Doyeon Hwang, Seokhun Yang, et al.
Eclinicalmedicine
|
January 9, 2026
Abbreviated dual antiplatelet therapy after percutaneous coronary intervention with ultrathin-strut drug-eluting stents in South Korea: 3-year outcomes of the multicentre, randomised HOST-IDEA trial
Jung-Kyu Han, Doyeon Hwang, Seokhun Yang, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)
|
August 24, 2023
Efficacy and safety of standard dose triple combination of telmisartan 80 mg/amlodipine 5 mg/chlorthalidone 25 mg in primary hypertension: A randomized, double-blind, active-controlled, multicenter phase 3 trial
Eun Joo Cho, Moo Hyun Kim, Young-Hak Kim, et al.
Trials
|
September 17, 2015
Harmonizing Optimal Strategy for Treatment of coronary artery diseases--comparison of REDUCtion of prasugrEl dose or POLYmer TECHnology in ACS patients (HOST-REDUCE-POLYTECH-ACS RCT): study protocol for a randomized controlled trial
Joo Myung Lee, Ji-Hyun Jung, Kyung Woo Park, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 51) with videos related to
Sort By:
Page
of 6
Clinical Therapeutics
|
October 10, 2025
Efficacy and Safety of Rosuvastatin/Amlodipine FDC in Patients With Hypertension and Dyslipidemia: A Multicenter, Prospective, Observational Study
Jae Hyoung Park, Kyung Hoon Cho, Seong-Il Woo, et al.
BMJ Open
|
October 14, 2017
Study protocol for a randomised controlled trial: harmonising optimal strategy for treatment of coronary artery stenosis - coronary intervention with next-generation drug-eluting stent platforms and abbreviated dual antiplatelet therapy (HOST-IDEA) trial
Chi-Hoon Kim, Jung-Kyu Han, Han-Mo Yang, et al.
Journal of Korean Medical Science
|
January 23, 2024
Prognostic Implication of Platelet Reactivity According to Left Ventricular Systolic Dysfunction Status in Patients Treated With Drug-Eluting Stent Implantation: Analysis of the PTRG-DES Consortium
Donghoon Han, Sun-Hwa Kim, Dong Geum Shin, et al.
Cardiovascular Therapeutics
|
August 11, 2016
Effect of fixed-dose combinations of ezetimibe plus rosuvastatin in patients with primary hypercholesterolemia: MRS-ROZE (Multicenter Randomized Study of ROsuvastatin and eZEtimibe)
Kyung-Jin Kim, Sang-Hyun Kim, Young Won Yoon, et al.
Clinical Therapeutics
|
November 16, 2019
Ezetimibe and Rosuvastatin Combination Treatment Can Reduce the Dose of Rosuvastatin Without Compromising Its Lipid-lowering Efficacy
Moo-Yong Rhee, Kyung-Jin Kim, Sang-Hyun Kim, et al.
European Heart Journal. Digital Health
|
July 24, 2025
Novel artificial intelligence model using electrocardiogram for detecting acute myocardial infarction needing revascularization
Kyung Hoon Cho, Young Hoon Ji, Sunghoon Joo, et al.
Circulation
|
March 5, 2023
Comparison of 3- to 6-Month Versus 12-Month Dual Antiplatelet Therapy After Coronary Intervention Using the Contemporary Drug-Eluting Stents With Ultrathin Struts: The HOST-IDEA Randomized Clinical Trial
Jung-Kyu Han, Doyeon Hwang, Seokhun Yang, et al.
Eclinicalmedicine
|
January 9, 2026
Abbreviated dual antiplatelet therapy after percutaneous coronary intervention with ultrathin-strut drug-eluting stents in South Korea: 3-year outcomes of the multicentre, randomised HOST-IDEA trial
Jung-Kyu Han, Doyeon Hwang, Seokhun Yang, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)
|
August 24, 2023
Efficacy and safety of standard dose triple combination of telmisartan 80 mg/amlodipine 5 mg/chlorthalidone 25 mg in primary hypertension: A randomized, double-blind, active-controlled, multicenter phase 3 trial
Eun Joo Cho, Moo Hyun Kim, Young-Hak Kim, et al.
Trials
|
September 17, 2015
Harmonizing Optimal Strategy for Treatment of coronary artery diseases--comparison of REDUCtion of prasugrEl dose or POLYmer TECHnology in ACS patients (HOST-REDUCE-POLYTECH-ACS RCT): study protocol for a randomized controlled trial
Joo Myung Lee, Ji-Hyun Jung, Kyung Woo Park, et al.
Page
of 6